Empower Advisory Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $333K | Sell |
2,193
-3,279
| -60% | -$498K | ﹤0.01% | 386 |
|
|
2025
Q1 | $824K | Sell |
5,472
-270,379
| -98% | -$40.7M | ﹤0.01% | 255 |
|
|
2024
Q4 | $50.9M | Buy |
275,851
+6,747
| +3% | +$1.25M | 0.17% | 112 |
|
|
2024
Q3 | $53M | Sell |
269,104
-3,497
| -1% | -$689K | 0.18% | 110 |
|
|
2024
Q2 | $56.3M | Buy |
272,601
+5,808
| +2% | +$1.2M | 0.21% | 102 |
|
|
2024
Q1 | $72.3M | Buy |
266,793
+10,597
| +4% | +$2.87M | 0.27% | 81 |
|
|
2023
Q4 | $60.6M | Buy |
256,196
+13,962
| +6% | +$3.3M | 0.24% | 95 |
|
|
2023
Q3 | $47.5M | Buy |
242,234
+22,516
| +10% | +$4.41M | 0.21% | 100 |
|
|
2023
Q2 | $46.2M | Buy |
219,718
+18,321
| +9% | +$3.85M | 0.2% | 115 |
|
|
2023
Q1 | $40.3M | Buy |
+201,397
| New | +$40.3M | 0.18% | 118 |
|